Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy

Acta Neuropathologica

Volumn 95, Issue 1, 1997, Pages 47-56

  Kalichman, Michael W ^a   Powell, Henry C ^a   Mizisin, Andrew P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Diabetic neuropathy; Galactose; Human; Rat; Schwann cell

Indexed keywords

ALDEHYDE REDUCTASE; FAT DROPLET; GALACTOSE; GLYCOGEN; POLYOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL MEMBRANE; CELL ORGANELLE; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; DEMYELINATION; DIABETIC NEUROPATHY; EXPERIMENTAL MODEL; HYPERGLYCEMIA; HYPOINSULINEMIA; INTOXICATION; MITOCHONDRION; NERVE BIOPSY; NERVE CELL DEGENERATION; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RAT; SCHWANN CELL; SURAL NERVE;

EID: 0031884263     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050764     Document Type: Article

References (55)

1. Adinolfi AM, Yamuy J, Morales FR, Chase MH (1991) Segmental demyelination in peripheral nerves of old cats. Neurobiol Aging 12: 175-179
2. Anderson TD, Davidovich A, Feldman D, Sprinkle TJ, Arezzo J, Brosnan C, Calderon RO, Fossom LH, DeVries JT, DeVries GH (1994) Mitochondrial Schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycitidine neurotoxicity. Lab Invest 70: 724-739
3. Ballin RH, Thomas PK (1968) Hypertrophic changes in diabetic neuropathy. Acta Neuropathol 11: 93-102
4. Bischoff A (1968) Diabetic neuropathy. Morbid anatomy, pathophysiology and pathogenesis based on electron-microscopic findings. Ger Med Month 13: 214-218
5. Bischoff A (1980) Morphology of diabetic neuropathy. Horm Metab Res Suppl 9: 18-28
6. Brett FM, Kalichman MW, Calcutt NA, Mizisin AP (1996) Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve. J Neurol Sci 141: 6-12
7. Byrd JC III, Powers JM (1979) Wolman's disease: ultrastructural evidence of lipid accumulation in central and peripheral nervous systems. Acta Neuropathol (Berl) 45: 37-42
8. Cameron NE, Cotter MA, Robertson S, Cox D (1992) Muscle and nerve dysfunction in rats with experimental galactosaemia. Exp Physiol 77: 89-108
9. Choo D, Malmgren LT, Rosenberg SI (1990) Age-related changes in Schwann cells of the internal branch of the rat superior laryngeal nerve. Otolaryngol Head Neck Surg 103:628-636
10. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF (1988) Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 319: 542-548
11. Eaton RP, Qualls C, Bicknell J, Sibbitt WL, King MK, Griffey RH (1996) Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis. Diabetologia 39: 439-446
12. Feldman D, Brosnan C, Anderson TD (1992) Ultrastructure of peripheral neuropathy induced in rabbits by 2′3′-dideoxycyti- dine. Lab Invest 66: 75-85
13. Ferrans VJ, Fredrickson DS (1975) The pathology of Tangier disease. A light and electron microscopic study. Am J Pathol 78: 101-158
14. Forcier NJ, Mizisin AP, Rimmer MA, Powell HC (1991) Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol Exp Neurol 50: 235-255
15. Gabbay KH, Snider JJ (1972) Nerve conduction defect in galactose-ted rats. Diabetes 21: 295-300
16. Giannini C, Dyck PJ (1996) Axoglial dysjunction: a critical appraisal of definition, techniques, and previous results. Microsc Res Tech 34: 436-444
17. Goodrum JF, Earnhardt TS, Goines ND, Bouldin TW (1990) Lipid droplets in Schwann cells during tellurium neuropathy are derived from newly synthesized lipid. J Neurochem 55:1928-1932
18. Griffey RH, Eaton RP, Gasparovic C, Sibbitt W (1987) Galactose neuropathy. Structural changes evaluated by nuclear magnetic resonance spectroscopy. Diabetes 36: 776-778
19. Griffey RH, Eaton RP, Sibbitt RR, Sibbitt WL, Bicknell JM (1988) Diabetic neuropathy. Structural analysis of nerve hydration by magnetic resonance spectroscopy. JAMA 260: 2872-2878
20. Hirano A (1978) A possible mechanism of demyelination of the Syrian hamster with hindleg paralysis. Lab Invest 38: 115-121
21. Jakobsen J (1978) Peripheral nerves in early experimental diabetes: expansion of the endoneurial space as a cause of increased water content. Diabetologia 14: 113-119
22. Johnson PC, Doll SC, Cromey DW (1986) Pathogenesis of diabetic neuropathy. Ann Neurol 19: 450-457
23. Jortner BS, Cherry J, Lidsky TI, Manetto C, Shell L (1987) Peripheral neuropathy of dietary riboflavin deficiency in chickens. J Neuropathol Exp Neurol 46: 544-555
24. Kalichman MW, Powell HC, Myers RR (1988) Pathology of local anesthetic-induced nerve injury. Acta Neuropathol (Berl) 75: 583-589
25. Kamijo M, Basso M, Cherian PV, Hohman TC. Sima AA (1994) Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy. Diabetes Res Clin Pract 25: 117-129
26. Kern TS, Engerman RL (1982) Immunohistochemical distribution of aldose reductase. Histochem J 14: 507-515
27. King RH, Llewelyn JG, Thomas PK, Gilbey SG, Watkins PJ (1989) Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy. Neuropathol Appl Neurobiol 15: 339-355
28. Krendel DA, Costigan DA, Hopkins LC (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52: 1053-1061
29. Lampert PW (1967) A comparative electron microscopic study of reactive, degenerating, regenerating, and dystrophic axons. J Neuropathol Exp Neurol 26: 345-368
30. Mizisin AP, Calcutt NA, DiStefano PS, Acheson A, Longo FM (1997) Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes 46: 647-652
31. Mizisin AP, Kalichman MW, Myers RR, Powell HC (1990) Role of the blood-nerve barrier in experimental nerve edema. Tox Pathol 18: 170-185
32. Mizisin AP, Powell HC (1993) Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 52: 78-86
33. Mizisin AP, Powell HC, Myers RR (1986) Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor. J Neurol Sci 74: 35-43
34. Olsson Y (1968) Mast cells in the nervous system. Int Rev Cytol 24: 27-70
35. Olsson Y (1971) Mast cells in human peripheral nerve. Acta Neurol Scand 47: 357-368
36. Origuchi Y, Miyoshino S, Mishima K, Mine K (1990) Quantitative histologic study of the sural nerve in Lesch-Nyhan syndrome. Pediatr Neurol 6: 353-355
37. Peripheral Nerve Society (1995) Diabetic poly neuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann Neurol 38: 478-482
38. Powell HC, Garrett RS, Kador PF, Mizisin AP (1991) Fine-structural localization of aldose reductase and ouabain-sensitive, K(+)-dependent p-nitro-phenylphosphatase in rat peripheral nerve. Acta Neuropathol 81: 529-539
39. Powell HC, Koch T, Garrett R, Lampen PW (1978) Schwann cell abnormalities in 2,5-hexanedione neuropathy. J Neurocytol 7:517-528
40. Powell HC, Myers RR (1983) Schwann cell changes and demyelination in chronic galactose neuropathy. Muscle Nerve 6: 218-227
41. Powell HC, Rosoff J, Myers RR (1985) Microangiopathy in human diabetic neuropathy. Acta Neuropathol (Berl) 68: 295-305
42. Schroder JM, Mayer M, Weis J (1996) Mitochondrial abnormalities and intrafamilial variability of sural nerve biopsy findings in adrenomyeloneuropathy. Acta Neuropathol 92: 64-69
43. Schroder JM, Sommer C (1991) Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy. hereditary and non-hereditary neuropathies, and review of the literature. Acta Neuropathol 82:471-482
44. Sima AA, Bouchier M, Christensen H (1983) Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy. Ann Neurol 13: 264-272
45. Sima AA, Nathaniel V, Bril V, McEwen TA, Greene DA (1988) Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349-364
46. Spencer PS. Schaumburg HH (1977) Ultrastructural studies of the dying-back process. III The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol 36: 276-299
47. Spencer PS, Thomas PK (1974) Ultrastructural studies of the dying-back process. II The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons. J Neurocytol 3: 763-783
48. Stewart MA, Sherman WR, Kurien MM, Moonsammy GI, Wisgerhof M (1967) Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosaemia. J Neurochem 14: 1057-1066
49. Thomas PK, Lascelles G (1966) The pathology of diabetic neuropathy. Q J Med 35: 489
50. Thomas PK, Tomlinson DR (1993) Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK. Griffin JW. Low PA, Poduslo JF (eds) Peripheral Neuropathy, 3rd edn, Saunders, Philadelphia, pp 1219-1250
51. Van Gerven JM, Tjon-A-Tsien AM (1995) The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation. Drugs Aging 6: 9-28
52. Webster H deF, Schroder JM, Asbury AK, Adams RD (1967) The role of Schwann cells in the formation of "onion-bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol 26: 276-299
53. Weis J, Dimpfel W, Schroder JM (1995) Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve 18: 175-184
54. Wuarin-Bierman L, Zahnd GR, Kaufmann F, Burcklen L, Adler J (1987) Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia 30: 653-658
55. Yagihashi S, Matsunaga M (1979) Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 129: 357-366